The aging mouse CNS is protected by an autophagy-dependent microglia population promoted by IL-34

Rasmus Berglund1, Yufei Cheng2, Eliane Piket2

  • 1Department of Clinical Neuroscience, Division of Neuro, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, 171 76, Stockholm, Sweden. rasmus.berglund@ki.se.

Nature Communications
|January 9, 2024
PubMed

Insights

Researchers discovered a neuroprotective microglia population in aging brains that relies on autophagy and IL-34. Enhancing this population may treat neuroinflammatory diseases like multiple sclerosis (MS).

Area of Science:

  • Neuroscience
  • Immunology
  • Cellular Biology

Background:

  • Microglia, the brain's immune cells, possess untapped potential for combating age-related neurodegenerative and neuroinflammatory diseases, such as progressive multiple sclerosis (MS).
  • Identifying specific microglial subtypes and their functions is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate a specific population of microglia in aging brains and determine its role in neuroinflammation and neuroprotection.
  • To elucidate the molecular mechanisms, including autophagy and cytokine signaling, regulating this microglia population.

Main Methods:

  • Analysis of microglial populations in aging mouse brains using phosphorylation patterns (ERK1/2, Akt, AMPK) and transcriptomics.
  • Genetic deletion of the autophagy gene Ulk1 in microglia.
  • Investigating the role of IL-34 and CSF1 signaling via CSF1R.
  • Inducing autoimmune neuroinflammation in aging mice to assess the impact of microglial modulation.

Main Results:

  • A distinct microglia population characterized by activated autophagy markers was identified in aging mouse cortex.
  • Deletion of Ulk1 in microglia reduced this population, while IL-34, not CSF1, was found to be essential for its maintenance.
  • Loss of autophagy-dependent microglia exacerbated neural and glial cell death and increased mortality during induced neuroinflammation.
  • IL-34-mediated expansion of microglia demonstrated a protective effect against neuroinflammation.

Conclusions:

  • An autophagy-dependent, IL-34-regulated microglia population exhibits neuroprotective functions in aging and neuroinflammatory conditions.
  • This specific microglial population represents a promising therapeutic target for age-related neuroinflammatory diseases, including progressive MS.